Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Presolicitation opportunity from Department Of Health And Human Services was posted on September 21, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NOI to Sole Source to Werfen USA LLC

Closed
NOI-OD-26-007532Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413
New
International
Тести швидкі для визначення інфекційних захворювань; Тести швидкі на кардіомаркери: ІХА, тест-касета/панель, для визначення тропоніну (TnI), матеріал цільна кров/сироватка/плазма, чутливість від 99%, специфічність від 99,7%; Тест швидкий для визначення ін
Solicitation # UA-2026-11-06-014296-a
This solicitation, issued by the Avdiivka Central City Hospital under the Government of Ukraine, seeks the procurement of rapid diagnostic tests for cardiomarkers and infectious diseases. The cardiomarker tests utilize the immunochromatographic analysis method in test-panel or cassette formats to detect Troponin (TnI) from whole blood, serum, or plasma, boasting a sensitivity of 99-100 percent and specificity of 99.7-100 percent. Additionally, the contract covers rapid tests for detecting COVID-19, Influenza A, and Influenza B antigens using mucus samples. These infectious disease tests also employ immunochromatographic analysis in a cassette format, with a reported sensitivity of 95-100 percent and specificity of 99-100 percent. The solicitation was posted on November 6, 2026, with a response deadline of November 10, 2026.
КОМУНАЛЬНЕ НЕКОМЕРЦІЙНЕ ПІДПРИЄМСТВО "АВДІЇВСЬКА ЦЕНТРАЛЬНА МІСЬКА ЛІКАРНЯ" АВДІЇЇВСЬКОЇ МІСЬКОЇ РАДИ

POSTED

2 days ago

DEADLINE

in 2 days
NAICS: 325413
New
International
Тест-смужки Accu-Chek Instant (НК 024:2023: 53304 Глюкоза IVD (діагностика in vitro), набір, колориметрична тест-стрічка, експрес-аналіз; НК 031:2024:W0101060101 ТЕСТ-СМУЖКИ ДЛЯ ВИМІРЮВАННЯ РІВНЯ ГЛЮКОЗИ); Тест-смужки GluNeo Lite для глюкометра (НК 024:20
Solicitation # UA-2026-11-06-013450-a
This solicitation, issued by the Nizhyn Central City Hospital named after Mykola Halytskyi under the Government of Ukraine, is for the procurement of glucose monitoring test strips, specifically Accu-Chek Instant and GluNeo Lite. The contract is identified by solicitation number UA-2026-11-06-013450-a and was posted on November 6, 2026, with a response deadline set for November 11, 2026. The performance of the contract will take place in Nizhyn, Chernihiv region, Ukraine. A critical compliance requirement for this tender is that the goods provided cannot originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. Interested parties may contact Nataliia Fil for further information regarding this procurement process.
КОМУНАЛЬНЕ НЕКОМЕРЦІЙНЕ ПІДПРИЄМСТВО "НІЖИНСЬКА ЦЕНТРАЛЬНА МІСЬКА ЛІКАРНЯ ІМЕНІ МИКОЛИ ГАЛИЦЬКОГО" НІЖИНСЬКОЇ МІСЬКОЇ РАДИ ЧЕРНІГІВСЬКОЇ ОБЛАСТІ

POSTED

2 days ago

DEADLINE

in 3 days
NAICS: 325413
New
International
Набір реагентів : визначення групи крові людини реагент анти-А IgM, матеріал дослідження: кров, метод дослідження: реакція прямої гемаглютинації/аглютинації, форма випуску: рідина по 10 м (НК 024:2023: 52532 - Анти-А групове типування еритроцитів IVD (діа
Solicitation # UA-2026-11-06-011431-a
This solicitation, issued by the Nizhyn Central City Hospital named after Mykola Halytskyi under the Government of Ukraine, is for the procurement of Anti-A IgM blood grouping reagents. The required materials are intended for human blood group determination using the direct hemagglutination method and must be supplied in liquid form in 10 ml units. The procurement process is identified by solicitation number UA-2026-11-06-011431-a, with a response deadline set for November 11, 2026. A critical compliance requirement specifies that the goods cannot originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. Performance of the contract will take place in Nizhyn, Chernihiv region, Ukraine.
КОМУНАЛЬНЕ НЕКОМЕРЦІЙНЕ ПІДПРИЄМСТВО "НІЖИНСЬКА ЦЕНТРАЛЬНА МІСЬКА ЛІКАРНЯ ІМЕНІ МИКОЛИ ГАЛИЦЬКОГО" НІЖИНСЬКОЇ МІСЬКОЇ РАДИ ЧЕРНІГІВСЬКОЇ ОБЛАСТІ

POSTED

2 days ago

DEADLINE

in 3 days
NAICS: 325413
New
International
Код ДК 021-2015 (CPV): 33120000-7 Системи реєстрації медичної інформації та дослідне обладнання; Тест-набори для кількісного визначення ріввня С-реактивного білка (СРБ) до аналізатора FIATEST, Тест-набори для кількісного визначення ріввня D-димер до ана
Solicitation # UA-2026-11-06-006484-a
The Pereyaslav Multidisciplinary Hospital of Intensive Care is conducting a procurement process for medical information registration systems and laboratory equipment. Specifically, the agency is seeking suppliers for test kits used in the quantitative determination of C-reactive protein and D-dimer levels compatible with the FIATEST analyzer. This solicitation is being carried out under the Law of Ukraine on Public Procurement and follows the procedures for selecting suppliers via price requests through the electronic catalog system. The procurement process began on November 6, 2026, with a response deadline set for November 12, 2026. A critical requirement for the selected supplier is the formal guarantee and confirmation that the provided goods do not originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. The contract is managed by the Government of Ukraine and will be performed in Pereyaslav, Kyiv region.
Комунальне некомерційне підприємство "Переяславська багатопрофільна лікарня інтенсивного лікування" Переяславської міської ради, Студениківської сільської ради, Ташанської сільської ради, Дівичківської сільської ради

POSTED

2 days ago

DEADLINE

in 4 days
NAICS: 325413
New
International
Набори реактивів та реагентів: контроль якості передстерилізаційного очищення та виявлення прихованої крові, метод дослідження: фотометричний метод, колориметричний метод, по 200 мл, Набори реактивів та реагентів: визначення забарвлення еозин метиленовий
Solicitation # UA-2026-11-06-004499-a
This solicitation, issued by the Bar Medical Center of Primary Health Care under the Bar City Council in Vinnytsia Oblast, Ukraine, seeks the procurement of various reagent kits for medical laboratory use. The requirements include reagents for quality control of pre-sterilization cleaning and the detection of occult blood using photometric and colorimetric methods in 200 ml volumes. Additionally, the contract covers May-Grunwald eosin methylene blue staining kits for microscopic visual analysis in 1000 ml volumes, as well as specialized reagents in 100 ml volumes designed to improve image quality for prepared microscopic samples. The procurement process is identified by solicitation number UA-2026-11-06-004499-a, with a posting date of November 6, 2026, and a response deadline of November 11, 2026. All specified analyses are qualitative and intended for manual execution. The primary point of contact for this government tender is Mykhailo Yuriyovych Lobatyuk, and the performance of the contract will take place in the city of Bar, Ukraine.
Комунальне некомерційне підприємство"Барський медичний центр первинної медико-санітарної допомоги" Барської міської ради

POSTED

2 days ago

DEADLINE

in 3 days

AI Contract Overview

Show more

The National Institutes of Health intends to award a one-year, firm fixed price sole source contract to Werfen USA LLC for the acquisition of HemoHub Software. This proprietary middleware and data management system is designed specifically for use with ACL TOP hemostasis analyzers currently operated by the DLM Hematology-Coagulation Laboratory at the NIH Clinical Center in Bethesda, Maryland. HemoHub provides essential functionalities including analyzer-specific QC management, calibration monitoring, clot curve analysis, and direct integration with instrument software that cannot be replicated by third-party vendors. Because Werfen exclusively develops, licenses, and supports HemoHub, no other vendor is authorized to provide the necessary integration, maintenance, or cybersecurity updates for the ACL TOP platform. This procurement is being conducted under the Federal Acquisition Regulation Simplified Acquisition Procedures, as the government has determined that only one source is reasonably available to meet the technical requirements. This notice serves as an intent to award rather than a request for quotations.

General Info

NIH sole source firm fixed price contract to Werfen USA for HemoHub Software.

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

1
DOCX, Low priority6 pages · justification-and-authorization
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more

The purpose of this procurement is to obtain the HemoHub Software. HemoHub is a proprietary middleware and data management system developed, licensed, supported, and distributed exclusively by Werfen for use with its ACL TOP hemostasis analyzers. No other vendor is authorized to provide, modify, support, maintain, or integrate HemoHub with the ACL TOP platform.


The DLM Hematology-Coagulation Laboratory currently operates two ACL TOP 750 analyzers manufactured by Werfen. HemoHub was specifically designed to interface directly with ACL TOP analyzers and provides unique functionality that is not available through third-party middleware products. These capabilities include analyzer-specific QC management, calibration monitoring, clot curve analysis, peer-group QC comparison, advanced coagulation workflow management, and direct integration with ACL TOP instrument software and databases.


•             Product Service Code: 6640 – Laboratory Equipment and Supplies


•             NAICS Code: 325413 – In-Vitro Diagnostic Substance Manufacturing


•             Place of Performance: NIH Clinical Center, Bethesda, MD 20892 USA


POTS: 26-007532


Description:


This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued, and quotations will not be requested.


The National Institutes of Health (NIH) intends to award a one-year contract to Werfen USA LLC, located at 180 Hartwell Rd, Bedford, MA 01730, on a firm fixed price sole source award basis for the acquisition of the HemoHub Software.


The purchase of HemoHub will provide a centralized data management and middleware solution specifically designed for hemostasis laboratories. HemoHub will receive, process, display, store, and manage data generated by the ACL TOP analyzers while providing enhanced oversight of instrument performance, QC activities, and patient testing workflows.


Because HemoHub is proprietary to Werfen, there are no equivalent commercial products that can provide the same level of native integration, functionality, performance monitoring, and technical support for the ACL TOP platform. Third-party middleware vendors do not have access to Werfen's proprietary analyzer architecture, software algorithms, instrument communication protocols, or specialized coagulation data management features required to provide comparable functionality.


In addition, ongoing software updates, validation support, maintenance, troubleshooting, cybersecurity updates, and technical support for HemoHub can only be provided by Werfen. Procurement from any other source is not possible because no other vendor is licensed or authorized to sell, implement, or support this software.


This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.


The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.


Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Huda Malik, Contract Specialist via email to contact@example.gov by September 24, 2026 at 2 pm EST.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 334516
New
Federal
CSS - Spectra-Physics InSight X3 Dual Laser System
Solicitation # 75N98027Q00072
The National Institutes of Health, on behalf of the National Heart, Lung, and Blood Institute, is soliciting a firm-fixed-price purchase order for one Brand Name Spectra-Physics InSight X3 Dual Ultrafast Laser System. This equipment will be integrated with an existing Thorlabs Veneto inverted multiphoton microscope to support Fluorescence Lifetime Imaging Microscopy and Stimulated Raman Scattering pump-probe experiments. The requirement includes a rack-mounted power supply, a closed-loop chiller, and essential services such as on-site factory installation, optical alignment, and operator training. Technical specifications require pulses of 100 fs or less, automated wavelength tuning from 680 nm to 1300 nm, and a second synchronized output at 1045 nm, all supported by a 12-month OEM factory warranty. This is a brand-name restricted solicitation under NAICS code 334516, and the requirement is unrestricted. To be considered technically acceptable, offerors other than the Original Equipment Manufacturer must provide an official Letter of Authorization verifying their status as an authorized distributor and confirming that the OEM will honor the installation, training, and warranty. Award will be based on best value, where technical capability, delivery schedule, and past performance are weighted as significantly more important than price. Proposals must be submitted by November 20, 2026, and must include a detailed price breakout, delivery timeframe, and a business size certification.
Analytical Laboratory Instrument Manufacturing

POSTED

2 days ago

DEADLINE

in 12 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS